Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy")

Biol Psychiatry. 1996 May 1;39(9):819-20. doi: 10.1016/0006-3223(95)00551-X.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Combined Modality Therapy
  • Depressive Disorder / chemically induced
  • Depressive Disorder / psychology
  • Depressive Disorder / rehabilitation
  • Female
  • Hallucinogens / administration & dosage
  • Hallucinogens / adverse effects*
  • Humans
  • Male
  • N-Methyl-3,4-methylenedioxyamphetamine / administration & dosage
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Substance-Related Disorders / psychology*
  • Substance-Related Disorders / rehabilitation
  • Suicide / psychology*

Substances

  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine